CIMETIDINE AND L-DOPA IN THE CONTROL OF PROLACTIN SECRETION IN MANPONTIROLI AE; PELLICCIOTTA G; ALBERETTO M et al.1979; HORMONE METABOL. RES.; DEU; DA. 1979; VOL. 11; NO 3; PP. 257-258; BIBL. 8 REF.Article

STUDY ON THE REPRODUCIBILITY OF HUMAN PROLACTIN RESPONSE TO SULPIRIDE, BENSERAZIDE, INSULIN HYPOGLYCAEMIA AND ARGININE INFUSIONPONTIROLI AE; GALA RR; PELLICCIOTTA G et al.1979; ACTA ENDOCRINOL.; DNK; DA. 1979; VOL. 91; NO 3; PP. 410-420; BIBL. 24 REF.Article

LASER PHOTOLYSIS STUDY OF THE HEMATOPORPHYRIN IX-L-TRYPTOPHAN SYSTEM IN SOLVENT MIXTURES AT DIFFERENT POLARITYMURGIA SM; PASQUA A; POLETTI A et al.1983; CHEMICAL PHYSICS LETTERS; ISSN 0009-2614; NLD; DA. 1983; VOL. 98; NO 2; PP. 179-183; BIBL. 15 REF.Article

BENSERAZIDE, A STIMULATOR OF PROLACTIN RELEASE: A NEW TEST IN THE DIAGNOSIS OF PITUITARY PROLACTIN SECRETIN TUMOURSPONTIROLI AE; FALSETTI L; VOLTOLINI AM et al.1981; ACTA ENDOCRINOL. (KBH.); ISSN 0001-5598; DNK; DA. 1981; VOL. 98; NO 3; PP. 326-332; BIBL. 19 REF.Article

REPEATED CIMETIDINE ADMINISTRATION REDUCES THE GROWTH HORMONE (GH) RESPONSE TO INSULIN-HYPOGLYCEMIAPONTIROLI AE; PELLICCIOTTA G; ALBERETTO M et al.1980; HORMONE METABOL. RES.; DEU; DA. 1980; VOL. 12; NO 4; PP. 172-173; BIBL. 11 REF.Article

ANTIHISTAMINICS H₁ AND H₂ DO NOT MODIFY THE HUMAN PROLACTIN RESPONSE TO ARGININE INFUSION AND INSULIN HYPOGLYCEMIAPONTIROLI AE; GALA RR; PELLICCIOTTA G et al.1980; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1980; VOL. 12; NO 10; PP. 557-558; BIBL. 7 REF.Article

Ageing and acetylator phenotype as determined by administration of sulphadimidinePONTIROLI, A. E; DE PASQUA, A; BONISOLLI, L et al.European journal of clinical pharmacology. 1985, Vol 28, Num 4, pp 485-486, issn 0031-6970Article

INTERACTION OF DOPAMINERGIC AND ANTISEROTONINERGIC DRUGS IN THE CONTROL OF PROLACTIN AND LH RELEASE IN NORMAL WOMENPONTIROLI AE; ALBERETTO M; PELLICCIOTTA G et al.1980; ACTA ENDOCRINOL.; DNK; DA. 1980; VOL. 93; NO 3; PP. 271-276; BIBL. 2 P.Article

THE EFFECT OF HISTAMINE AND H₁ AND H₂ RECEPTORS ON PROLACTIN AND LUTEINIZING HORMONE RELEASE IN HUMANS: SEX DIFFERENCES AND THE ROLE OF STRESSPONTIROLI AE; DE CASTRO E; MAZZOLENI F et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 5; PP. 924-928; BIBL. 32 REF.Article

Puerperal lactation, gonadotropin release and estradiol release: effects of metergoline and bromocriptinePONTIROLI, A. E; DI MICCO, R; SARTANI, A et al.Gynecologic and obstetric investigation. 1987, Vol 24, Num 3, pp 179-184, issn 0378-7346Article

Effect of metergoline on prolactin, follicle stimulating hormone, luteinizing hormone and thyroid stimulating hormone response to TRH and LHRH in normal men and womenSARTANI, A; DE PASQUA, A; CESATI, R et al.Hormone and metabolic research. 1984, Vol 10, Num 16, pp 535-538, issn 0018-5043Article

The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groupsPONTIROLI, A. E; MOSCA, A; DE PASQUA, A et al.Diabetologia (Berlin). 1984, Vol 27, Num 2, pp 235-237, issn 0012-186XArticle

Determination of polymyxin E₁ in rat plasma by high-performance liquid chromatographyGMUR, Dennis J; BREDL, Charles R; STEELE, Sharon J et al.Journal of chromatography. B. 2003, Vol 789, Num 2, pp 365-372, issn 1570-0232, 8 p.Article

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosisGELLER, David E; PITLICK, William H; NARDELLA, Pasqua A et al.Chest. 2002, Vol 122, Num 1, pp 219-226, issn 0012-3692Article

Acute superior vena cava and right atrial tamponade in an infant after open heart surgeryPIERLI, C; IADANZA, A; DEL PASQUA, A et al.International journal of cardiology. 2002, Vol 83, Num 2, pp 195-197, issn 0167-5273Article

bcl-2, bax, bcl-x_L, and bcl-x_S expression in normal and neoplastic ovarian tissuesMARONE, M; SCAMBIA, G; MOZZETTI, S et al.Clinical cancer research. 1998, Vol 4, Num 2, pp 517-524, issn 1078-0432Article

Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and RH blood groupsPONTIROLI, A. E; CALDERARA, A; BONISOLLI, L et al.Diabète et métabolisme (Paris). 1987, Vol 13, Num 4, pp 444-449, issn 0338-1684Article

Bcl-2, bax, Bcl-x_L and Bcl-x_s expression in neoplastic and normal endometriumMARONE, M; FERRANDINA, G; MACCHIA, G et al.Oncology. 2000, Vol 58, Num 2, pp 161-168, issn 0030-2414Article

SPα^I/65 hereditary elliptocytosis in Calabria (southern Italy)QUALTIERI, A; BISCONTE, M. G; PASQUA, A et al.Human genetics. 1995, Vol 95, Num 3, pp 359-362, issn 0340-6717Article

Dye-sensitized photo-oxidation of pig kidney Dopa decarboxylasePASQUA, A; DOMINICI, P; MURGIA, S. M et al.Biochemistry international. 1984, Vol 9, Num 4, pp 437-446, issn 0158-5231Article

HB Prato [α31(B12)ARG→SER] in a Calabrian familyDE MARCO, E. V; CRESCIBENE, L; PASQUA, A et al.Hemoglobin. 1992, Vol 16, Num 4, pp 275-279, issn 0363-0269Article

Spectrin cosenza: a novel β chain variant associated with Sp α^I/74 hereditary elliptocytosisQUALTIERI, A; PASQUA, A; BISCONTE, M. G et al.British journal of haematology. 1997, Vol 97, Num 2, pp 273-278, issn 0007-1048Article

Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary careLAPI, F; SIMONETTI, M; MICHIELI, R et al.Bone (New York, NY). 2012, Vol 50, Num 1, pp 85-90, issn 8756-3282, 6 p.Article

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancerFERRANDINA, G; FAGOTTI, A; SALERNO, M. G et al.British journal of cancer. 1999, Vol 81, Num 4, pp 733-740, issn 0007-0920Conference Paper

NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern ItalySPADAFORA, P; ANNESI, G; ANNESI, F et al.Neuroscience letters. 2003, Vol 351, Num 2, pp 75-78, issn 0304-3940, 4 p.Article